
CAS 1135231-62-7
:Lidocaine EP impure E Hydrochloride
Description:
Lidocaine EP impure E Hydrochloride, with the CAS number 1135231-62-7, is a local anesthetic commonly used in medical applications to provide temporary pain relief. It is a derivative of lidocaine, which is known for its effectiveness in blocking nerve signals in the body. The "EP" designation indicates that it meets the standards set by the European Pharmacopoeia, while "impure" suggests that the substance may contain varying levels of impurities or by-products from its synthesis. As a hydrochloride salt, it is typically more soluble in water than its base form, enhancing its bioavailability for injection or topical application. Lidocaine acts by inhibiting sodium ion channels, thereby preventing the propagation of action potentials in nerves. Its characteristics include a relatively rapid onset of action and a moderate duration of effect, making it suitable for various medical procedures. However, the presence of impurities may affect its efficacy and safety profile, necessitating careful consideration in clinical use.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
Lidocaine EP Impurity E (as Hydrochloride)
CAS:Controlled ProductFormula:C20H25N3O2·ClHColor and Shape:NeatMolecular weight:375.892,2’-Iminobis(N-(2,6-Dimethylphenyl)acetiamide-d12 Hydrochloride
CAS:Controlled ProductFormula:C20D12H13N3O2·HClColor and Shape:NeatMolecular weight:387.966N-(2,6-Dimethylphenyl)-2-({[(2,6-dimethylphenyl)carbamoyl]methyl}amino)acetamide hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C20H26ClN3O2Purity:Min. 95%Molecular weight:375.9 g/mol



